Author Archive | Rod Raynovich

Raygent Biopharmaceutical Stock Portfolio beats the market for 2008

buy prednisone 5mg My biotech picks were published in Genetic Engineering News (GEN) in February 2008. My strategy was to allocate 25% in one ETF (XBI), 50% in large caps and 25% in smaller cap biotechs. My proprietary system is based on technicals, core technology and company financials. Despite all the volatility in 2008 with declines of 34-40% for […]

Continue Reading 0